Home / Medical Devices / Transdermal Skin Patches Market By Product (Matrix, Drug In Adhesive, Reservoir, Multilaminate), By Application (Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Motion Sickness, Neurological Disorder, Cardiovascular Disorder) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Transdermal Skin Patches Market By Product (Matrix, Drug In Adhesive, Reservoir, Multilaminate), By Application (Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Motion Sickness, Neurological Disorder, Cardiovascular Disorder) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Published: Sep 2017 | Report Code: 58679-09-17

Transdermal skin patches is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medical through the skin and in the bloodstream. The patch contains the medication prescribed to the patient and is designed in such a way that the medication permeates the skin in a controlled fashion thus attaining more steady levels of the drug in the body.

The report titled “Global Transdermal Skin Patches Market- Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall transdermal skin patches market along with the market size and estimates for the duration 2017 to 2025. The research study covers in-depth analysis of market segments based on product type, application type and different geographical region.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global transdermal skin patches market, attractive investment proposition and market positioning of key manufacturers sections.

Geographically, the global transdermal skin patches market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global transdermal skin patches market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global transdermal skin patches market. This report concludes with company profiles section that highlights major information about the key players engaged in global transdermal skin patches market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report. 

Thus, the research study provides a holistic view of the global transdermal skin patches market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Transdermal Skin Patches Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Transdermal Skin Patches Market Portraiture
2.2 Transdermal Skin Patches Market, by Product Type, 2016 (US$ Mn)
2.3 Transdermal Skin Patches Market, by Application Type, 2016 (US$ Mn)
2.4 Transdermal Skin Patches Market, by Geography, 2016 (Value %)

Chapter 3 Global Transdermal Skin Patches Market Analysis
3.1 Global Transdermal Skin Patches Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Mergers, Acquisition and Business Strategies
3.4 Porter’s Analysis
Credence Research, Inc. 4
3.5 Attractive Investment Proposition
3.6 Competitive Analysis: Global Transdermal Skin Patches Market, 2016 (Value %)

Chapter 4 Global Transdermal Skin Patches Market Analysis, By
Product Type
4.1 Overview
4.1.1 Market Attractive Proposition of Transdermal Skin Patches Market, by
Product Type, 2016
4.1.2 Top 3 Countries
4.2 Matrix
4.3 Drug in Adhesive
4.4 Reservoir
4.5 Multilaminate

Chapter 5 Global Transdermal Skin Patches Market Analysis, By
Application Type
5.1 Overview
5.1.1 Market Attractive Proposition of Transdermal Skin Patches Market, by
Application Type, 2016
5.1.2 Top 3 Countries, By Application Type (US$ Mn), 2015– 2025 (Value)
5.2 Pain Relief
5.3 Nicotine Cessation
5.4 Hormone Replacement Therapy
5.5 Motion Sickness
5.6 Neurological Disorder
5.7 Cardiovascular Disorder
5.8 Others

Chapter 6 Global Transdermal Skin Patches Market, By Geography
6.1 Preface
Credence Research, Inc. 5
6.2 North America (U.S. & Canada)
6.2.1 North America Transdermal Skin Patches Market, by Product Type, 2015-
2025 (US$ Mn)
6.2.2 North America Transdermal Skin Patches Market, by Application Type,
2015-2025 (US$ Mn)
6.2.3 North America Transdermal Skin Patches Market, by Country, 2015 – 2025
(US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Transdermal Skin Patches Market, by Product Type, 2015-2025
(US$ Mn)
6.3.2 Europe Transdermal Skin Patches Market, by Application Type, 2015-2025
(US$ Mn)
6.3.3 Europe Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$
Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Transdermal Skin Patches Market, by Product Type, 2015-2025
(US$ Mn)
6.4.2 Asia Pacific Transdermal Skin Patches Market, by Application Type, 2015-
2025 (US$ Mn)
6.4.3 Asia - Pacific Transdermal Skin Patches Market, by Country, 2015 – 2025
(US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Transdermal Skin Patches Market, by Product Type, 2015-
2025 (US$ Mn)
6.5.2 Latin America Transdermal Skin Patches Market, by Application Type,
2015-2025 (US$ Mn)
6.5.3 Latin America Transdermal Skin Patches Market, by Country, 2015 – 2025
(US$ Mn)
6.6 Middle East and Africa
Credence Research, Inc. 6
6.6.1 Middle East and Africa Transdermal Skin Patches Market, by Product
Type, 2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Transdermal Skin Patches Market, by Application
Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Transdermal Skin Patches Market, by Country,
2015 – 2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 ProSolus, Inc.
7.3 Medipatch, Inc,
7.4 AdhexPharma
7.5 Aneva Drug Delivery Systems
7.6 Medherant Limited
7.7 Allergan plc
7.8 NITTO DENKO CORPORATION
7.9 Mylan Pharmaceutical, Inc.
7.10 Corium International, Inc.
7.11 Noven Pharmaceuticals, Inc.
7.12 Teva Pharmaceuticals, Inc.
7.13 Johnson & Johnson, Inc.
7.14 Access Pharmaceuticals Inc.
Credence Research, Inc. 7

List of Tables :

TABLE 1 Top 3 Countries, By Product Type (US$ Mn), 2015– 2025 (Value)
TABLE 2 Global Transdermal Skin Patches Market, By Product Type (US$ Mn), 2015– 2025 (Value)
TABLE 3 Top 3 Countries, By Application Type (US$ Mn), 2015– 2025 (Value)
TABLE 4 Global Transdermal Skin Patches Market, By Application Type (US$ Mn), 2015– 2025 (Value)
TABLE 5 Global Transdermal Skin Patches Market, by Geography, 2015 – 2025 (US$ Mn) Credence Research, Inc. 8
TABLE 6 North America Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 8 North America Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 14 Asia - Pacific Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Transdermal Skin Patches Market, by Applications Type, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 22 ProSolus, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 23 Medipatch, Inc,: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 24 AdhexPharma: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 25 Aneva Drug Delivery Systems: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) Credence Research, Inc. 9
TABLE 26 Medherant Limited: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 27 Allergan plc: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 28 NITTO DENKO CORPORATION: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 29 Mylan Pharmaceutical, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 30 Corium International, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 31 Noven Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 32 Teva Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 33 Johnson & Johnson, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 34 Access Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)

List of Figures :

FIG. 1 Transdermal Skin Patches Market: Research Methodology
FIG. 2 Transdermal Skin Patches Market, by Product Type, 2016 (US$ Mn)
FIG. 3 Transdermal Skin Patches Market, by Application Type, 2016 (US$ Mn)
FIG. 4 Transdermal Skin Patches Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition
FIG. 6 Competitive Analysis: Global Transdermal Skin Patches Market, 2016 (Value %)
FIG. 7 Global Matrix Market(US$ Mn), 2015-2025
FIG. 8 Global Drug in Adhesive Market(US$ Mn), 2015-2025
FIG. 9 Global Reservoir Market (US$ Mn), 2015-2025
FIG. 10 Global Multilaminate Market (US$ Mn), 2015-2025
FIG. 11 Global Pain Relief Market(US$ Mn), 2015-2025
FIG. 12 Global Nicotine Cessation Market(US$ Mn), 2015-2025
FIG. 13 Global Hormone Replacement Therapy Market (US$ Mn), 2015-2025
FIG. 14 Global Motion Sickness Market (US$ Mn), 2015-2025
FIG. 15 Global Neurological Disorder Market (US$ Mn), 2015-2025
FIG. 16 Global Cardiovascular Disorder Market(US$ Mn), 2015-2025
FIG. 17 Global Others Applications Market(US$ Mn), 2015-2025

Based on the type of product, the transdermal skin patches market is segmented into:

  • Matrix
  • Drug in Adhesive
  • Reservoir
  • Vapor

Transdermal patches is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medical through the skin and in the bloodstream. The patch contains the medication prescribed to the patient and is designed in such a way that the medication permeates the skin in a controlled fashion thus attaining more steady levels of the drug in the body. Patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication. Based on the type of product type, the transdermal skin patches market is categorized into matrix, drug in adhesive, reservoir and vapor. The matrix segment held the largest share in the overall transdermal skin patches market due to product modification in terms of controlled release setting. Moreover, non-toxic and non-antagonistic characteristics of polymer matrix options, which are known to diffuse drug with controlled precision would further drive the market in the future.

Transdermal Skin Patches Market

Based on the type of application, the transdermal skin patches market is segmented into:

  • Pain Relief
  • Nicotine Cessation
  • Hormone replacement therapy
  • Motion Sickness
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others

Transdermal skin patches offer many advantages over other drug delivery methods like pill, powder, or liquid medication. The most vital benefit of skin patches is that it deliver the drug directly in the bloodstream, bypassing the liver’s metabolic activity. The second benefit of using patches is that medication is supplied gradually and constantly, rather than in a large, single dose which is advised in many therapeutic condition. On the basis of application the transdermal skin patches are segmented into pain relief, nicotine cessation, hormone replacement therapy, motion sickness, neurological disorders, cardiovascular disorders, and others. Transdermal patches for pain relief is the major contributing market as they are preferred over hypodermic injections, which are more painful, generate medical waste, and pose a risk of disease transmission. Improved patient compliance as the treatment is non-invasive, simple, and convenient, and there is greater flexibility in termination of drugs by the removal of patches.

Transdermal Skin Patches Market

For the purpose of this study, the global transdermal skin patches market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Transdermal Skin Patches Market

 For the purpose of this study, the global transdermal skin patches is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In the base year 2016, North America dominated the global medical foods market which was followed by Europe.  The key market drivers assisting in the growth of North America transdermal skin patches comprises rise in research and development in non-invasive methods of treatment for chronic conditions such as pain relief, motion sickness and other lifestyle related disorders. Moreover, the developed countries like U.S. U.K and others in North America and Europe, the adoption rate of the non-invasive and novel treatment is more than the developing nations. However, Asia Pacific has emerged as the fastest growing region in the transdermal skin patches market due to rising demand for better treatment at affordable cost in the region. Furthermore, innovation and government funding in the development of cutting-edge technology and healthcare infrastructure would augment the growth of Asia Pacific transdermal skin patches market.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients